1. Home
  2. STEM vs ONCY Comparison

STEM vs ONCY Comparison

Compare STEM & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stem Inc.

STEM

Stem Inc.

HOLD

Current Price

$9.69

Market Cap

82.6M

Sector

Technology

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.96

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEM
ONCY
Founded
2009
1998
Country
United States
Canada
Employees
423
N/A
Industry
Computer Software: Prepackaged Software
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.6M
94.0M
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
STEM
ONCY
Price
$9.69
$0.96
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$17.00
$7.33
AVG Volume (30 Days)
167.8K
981.2K
Earning Date
03-04-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$156,266,000.00
N/A
Revenue This Year
$9.81
N/A
Revenue Next Year
$14.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.08
N/A
52 Week Low
$0.29
$0.33
52 Week High
$32.23
$1.51

Technical Indicators

Market Signals
Indicator
STEM
ONCY
Relative Strength Index (RSI) 33.87 43.70
Support Level $0.41 $0.90
Resistance Level $12.05 $1.08
Average True Range (ATR) 0.93 0.06
MACD 0.10 -0.01
Stochastic Oscillator 2.98 6.49

Price Performance

Historical Comparison
STEM
ONCY

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: